Gillian C. Ivers-Read

Gillian C. Ivers-Read is a declared insider at 2 companies; the most frequent names are Clovis Oncology, Inc. and Pharmion Corp. We count 159 filings; the first trade dates from 24 August 2007 and the latest from 2 November 2022.

Both buying and selling appear: 1 purchase worth €51k, against 75 sales worth €3.7M. On balance, insiders were net sellers of €3.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 10 share grants and 68 option exercises. Since January 2022: no purchases and 12 sales on the market.

Most recently, on 3 November 2022, the filings show an open-market sale worth €1,996 in Clovis Oncology, Inc. The last insider purchase was made public on 21 November 2011, 5,450 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.